Legal experts watch as the medical community debates potential recall of the diabetes drug Avandia, made by GlaxoSmithKline PLC. Studies have linked the drug to increased risk of heart attack. At issue is the broader matter of drug safety policy after products have already received FDA approval.
Glaxo faces up to 11,000 cases in federal and state courts, according to an article in today's Wall Street Journal titled "FDA Faces Avandia Decision." The firm has settled almost 700 cases in recent weeks.
Many plaintiff law firms continue to offer consumers assistance with Avandia-related complications, based on a quick Google search for Internet marketing campaigns, including Sokolove Law, Ashcraft & Gerel, Steigerwalt & Associates, and Phillips & Associates.
Read more about the Avandia debate on the Wall Street Journal's Health Blog.
Monday, July 12, 2010
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment